Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells

Area of Science:

• Regenerative Medicine
• Developmental Biology
• Otic Stem Cell Biology

Background:

• Human induced pluripotent stem cells (iPSC) and embryonic stem cells (ESC) show promise for cell replacement therapies.
• Current limitations include low yields and heterogeneous cell populations, hindering stem cell therapy progress.
• Inner ear cell replacement therapies require efficient generation of functional hair cells and spiral ganglion neurons (SGN).

Purpose of the Study:

• To generate a fate-restricted immortalized multipotent otic progenitor (iMOP) cell line.
• To establish protocols for efficient differentiation of iMOP cells into hair cells and SGNs for inner ear therapies.
• To utilize iMOP cells for understanding inner ear neurosensory progenitor cell fate decisions.

Main Methods:

• Generation of a novel iMOP cell line from dissociated single cells.
• Protocols involving basic fibroblast growth factor (bFGF) withdrawal to promote cell cycle exit and differentiation.
• EdU cell proliferation assays to confirm decreased proliferation.
• Immunostaining for molecular markers (Cdkn1b, Cdh1, Tubb3) to confirm differentiation into inner ear sensory epithelia and neurons.

Main Results:

• Successful generation of an iMOP cell line.
• bFGF withdrawal significantly reduced iMOP cell proliferation.
• iMOP-derived cells expressed key molecular markers and exhibited morphological changes indicative of differentiation into inner ear sensory epithelia and neurons.
• Validated immunostaining protocols for Cdkn1b, Cdh1, and Tubb3 to identify differentiated cell types.

Conclusions:

• The iMOP cell line is a valuable tool for generating large numbers of functional inner ear cells.
• This method facilitates understanding of cell fate decisions in otic progenitors.
• The developed protocols accelerate the generation of otic cells for potential replacement therapies, addressing limitations in current stem cell approaches.